Drug Shortage Report for SANDOZ ANAGRELIDE

Last updated on 2018-09-10 History
Report ID 48791
Drug Identification Number 02260107
Brand name SANDOZ ANAGRELIDE
Common or Proper name ANAGRELIDE
Company Name SANDOZ CANADA INCORPORATED
Market Status CANCELLED POST MARKET
Active Ingredient(s) ANAGRELIDE
Strength(s) 0.5MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100S
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-05-04
Estimated end date 2018-09-03
Actual end date 2018-09-03
Shortage status Resolved
Updated date 2018-09-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2018-09-10 French Compare
v11 2018-09-10 English Compare
v10 2018-09-10 French Compare
v9 2018-09-10 English Compare
v8 2018-08-29 French Compare
v7 2018-08-29 English Compare
v6 2018-08-23 French Compare
v5 2018-08-23 English Compare
v4 2018-08-13 French Compare
v3 2018-08-13 English Compare
v2 2018-05-07 French Compare
v1 2018-05-07 English Compare

Showing 1 to 12 of 12